Promoting Partnerships To Improve Veterans’ Health

Appropriations, Rescissions, and the Road Ahead for VA Research

2 Sep 2025 12:44 PM | Elizabeth Stout (Administrator)

September is shaping up to be a decisive month for the federal budget and for the future of research funding. With the fiscal year ending on September 30, Congress faces a tight timeline to keep the government open while debating funding levels for 2026.

The administration’s FY26 request called for historic cuts to non-defense programs—a 23% overall reduction. Specific proposals included:

  • NIH: –44%

  • NSF: –55.8%

  • HUD: –43.6%

  • State Department: –84%

These reductions, if enacted, would have had devastating consequences for U.S. science and global competitiveness.

Both the House and Senate have moved in the opposite direction:

  • NIH: House set funding at $48 billion, while the Senate approved a $400 million increase over FY25.

  • NSF: House reduced NSF by $2 billion compared to FY25 (still $3 billion above the administration’s request); the Senate held NSF flat at current levels.

  • DOE Office of Science: House provided a $160 million increase.

However, even when Congress appropriates funding, the administration may withhold or rescind it.

  • In July, $8 billion was clawed back from foreign aid, NPR, and PBS.

  • In August, another $5 billion in foreign aid was targeted through a “pocket rescission” tactic, previously flagged by GAO as unlawful.

This creates significant uncertainty for agencies and institutions: will appropriated research dollars actually be released?

Without a continuing resolution (CR), the government will shut down on October 1. A CR requires bipartisan Senate support, which may be difficult to achieve given rescission fights and election-year politics. A shutdown this fall remains a real possibility.

Even if Congress acts to protect science funding, uncertainty around implementation could slow or stall critical work. Risks include:

  • Delayed or withheld NIH and NSF funding for new grants and projects.

  • Uncertainty for labs and training programs that depend on timely disbursements.

  • Potential “brain drain” as U.S. scientists consider moving abroad to more stable research environments.

As September unfolds, NAVREF will continue to monitor appropriations, rescissions, and shutdown negotiations closely. 



1717 K ST NW Suite 900

Washington, DC 20006

admin@navref.org

703-202-8113

FEIN: 52-1784596

Powered by Wild Apricot Membership Software